Hinnuliquinone, a C2-symmetric dimeric non-peptide fungal metabolite inhibitor of HIV-1 protease (original) (raw)

New Active HIV-1 Protease Inhibitors Derived from 3-Hexanol: Conformation Study of the Free Inhibitors in Crystalline State and in Complex with the Enzyme

Jindřich Hašek

Chemical Biology & Drug Design, 2012

View PDFchevron_right

Structure-Based Design of HIV Protease Inhibitors: Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors

Barry Finzel

Journal of Medicinal Chemistry, 1996

View PDFchevron_right

Pentacycloundecane-diol-Based HIV-1 Protease Inhibitors: Biological Screening, 2 D NMR, and Molecular Simulation Studies

Bahareh Honarparvar, Yasien Sayed

ChemMedChem, 2012

View PDFchevron_right

Potent New Antiviral Compound Shows Similar Inhibition and Structural Interactions with Drug Resistant Mutants and Wild Type HIV-1 Protease †

Yuan-fang Wang, Irene Weber

Journal of Medicinal Chemistry, 2007

View PDFchevron_right

Synthesis of 5,6-Dihydro-4-hydroxy-2- pyrones as HIV-1 Protease Inhibitors: The Profound Effect of Polarity on Antiviral Activity

Edmund Ellsworth

Journal of Medicinal Chemistry, 1997

View PDFchevron_right

Inhibitors of HIV Protease: Unique Non‐peptide Active Site Templates

Christopher Gajda

Journal of Molecular Recognition, 1996

View PDFchevron_right

Novel Protease Inhibitors (PIs) Containing Macrocyclic Components and 3(R),3a(S),6a(R)-bis-Tetrahydrofuranylurethane That Are Potent against Multi-PI-Resistant HIV-1 Variants In Vitro

Masayuki Amano

Antimicrobial Agents and Chemotherapy, 2010

View PDFchevron_right

An Orally Bioavailable HIV1 Protease Inhibitor Containing an Imidazole-Derived Peptide Bond Replacement: Crystallographic and Pharmacokinetic Analysis

Sherin S. Abdel-Meguid

Biochemistry, 1994

View PDFchevron_right

Design, Synthesis, and Biological and Structural Evaluations of Novel HIV-1 Protease Inhibitors To Combat Drug Resistance

Md Akbar Ali

Journal of Medicinal Chemistry, 2012

View PDFchevron_right

Structure-Based Design of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance

Hiroyuki Gatanaga

J. Med. …, 2006

View PDFchevron_right

Discovery and optimization of nonpeptide HIV-1 protease inhibitors

John Domagala

Bioorganic & Medicinal Chemistry, 1996

View PDFchevron_right

INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design 1

Alexander Wlodawer

Annual Review of Biophysics and Biomolecular Structure, 1998

View PDFchevron_right

Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds

deepak gupta

Biochemical and Biophysical Research Communications, 2012

View PDFchevron_right

The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains

Emilio Emini

Bioorganic & Medicinal Chemistry Letters, 2003

View PDFchevron_right

Future appeal of comparative studies on putative binding sites of HIV-1 virus-encoded proteolytic enzyme inhibitor of different Food and Drug Administration-approved compounds

SAMI MELEBARI

HIV & AIDS Review

View PDFchevron_right

Novel Insight into Inhibitor Binding of Highly Symmetric HIV-1 Protease

German Erlenkamp

ChemBioChem, 2008

View PDFchevron_right

Design, Synthesis, Evaluation, and Crystallographic-Based Structural Studies of HIV1 Protease Inhibitors with Reduced Response to the V82A Mutation

F. Javier Sardina

Journal of Medicinal Chemistry, 2008

View PDFchevron_right

Pentacycloundecane-based Inhibitors of Wild-type C-South African HIV Protease

Katja Petzold, Yasien Sayed

Bioorganic & medicinal …, 2011

View PDFchevron_right

Potent 7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid-Based Macrocyclic Inhibitors of Hepatitis C Virus NS3 Protease

Andrew Prongay

Journal of Medicinal Chemistry, 2006

View PDFchevron_right

JE2147: A Dipeptide Protease Inhibitor (PI) That Potently Inhibits Multi-PI-Resistant HIV1

John Erickson

Proceedings of The National Academy of Sciences, 1999

View PDFchevron_right

An in silico pharmacological approach toward the discovery of potent inhibitors to combat drug resistance HIV‐1 protease variants

Ishwar Chandra D

Journal of Cellular Biochemistry, 2018

View PDFchevron_right

Design and synthesis of sulfoximine based inhibitors for HIV1 protease

Abbas Raza

Bioorganic & Medicinal Chemistry Letters, 2008

View PDFchevron_right